What is Ynsect?
Founded in 2011 by scientists and environmental activists, Ynsect is at the forefront of realizing the full potential of mealworms for human and animal consumption, as well as for fertilizer applications. The company's proprietary technology and industrial-scale production processes position it as a leader in the burgeoning insect protein market. Ynsect's mission is to provide sustainable, high-quality protein sources that address global food security challenges and reduce environmental impact, contributing to a more circular economy.
How much funding has Ynsect raised?
Ynsect has raised a total of $403.3M across 6 funding rounds:
Angel/Seed
$2.5M
Series A
$6.6M
Series B
$15.2M
Other Financing Round
$65M
Debt
$139M
Other Financing Round
$175M
Angel/Seed (2014): $2.5M with participation from Demeter Partners and Emertec Gestion
Series A (2015): $6.6M led by Emertec Gestion, New Protein Capital, and Demeter Partners
Series B (2016): $15.2M supported by Emertec, Future Positive Capital, Demeter Partners, VisVires Capital, New Protein Capital, and Bpifrance Ecotechnologies
Other Financing Round (2020): $65M featuring Happiness Capital, Supernova Invest, Upfront, Astanor Ventures, Armat Group Capital, and FootPrint
Debt (2020): $139M backed by Caisse d’Epargne Hauts-de-France, Crédit Agricole Brie Picard, and Caisse des Dépôts
Other Financing Round (2023): $175M, investors not publicly disclosed
Key Investors in Ynsect
Happiness Capital
Happiness Capital is an investment firm that focuses on companies aiming to improve human well-being and societal progress. Their investment in Ynsect suggests a strategic alignment with sustainable food systems and innovative solutions for global challenges.
Supernova Invest
Supernova Invest is a venture capital firm specializing in deeptech and high-growth startups. Their backing of Ynsect indicates a belief in the company's technological innovation and its potential to disrupt traditional industries with sustainable solutions.
Astanor Ventures
Astanor Ventures is a venture capital firm dedicated to investing in sustainable food and agriculture technologies. Their participation in Ynsect's funding round underscores the company's commitment to advancing the insect protein industry for a more sustainable future.
What's next for Ynsect?
The recent major strategic investment signals Ynsect's transition into a significant growth phase, likely focused on expanding its production capacity, further developing its product portfolio, and strengthening its global market presence. This capital infusion will enable the company to scale its operations, enhance its R&D efforts, and solidify its position as a key player in the alternative protein landscape. Ynsect's strategic financing indicates a clear path towards commercial expansion and market leadership in sustainable insect-based solutions.
See full Ynsect company page
